Clinical Trial Update: LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

LOAd703, an oncolytic virus therapy, was studied in a Phase 1/2 trial for pancreatic cancer and the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• LOAd703

Snippet

Sponsor: Lokon Pharma AB | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED